Elona Kogan
Chief Legal Officer

Ms. Kogan joins Terns with over 20 years of life science experience leading companies through transformational change. Most recently, Ms. Kogan was Chief Legal Officer at Seer, Inc., where she advised management and the board of directors in a highly successful IPO and the commercialization of the company’s proteomic portfolio. 

Prior to that, Ms. Kogan held varying roles of increasing responsibility as head of legal and government affairs at companies developing medicines in therapeutic areas including oncology, cardiovascular, and central nervous system disorders. Ms. Kogan was a key executive at three biotechnology companies through acquisitions by Takeda Pharmaceuticals, Otsuka Pharmaceutical Ltd., and Pfizer. Her career reflects expertise in designing and executing complex transactions totaling over $10 billion in M&A and divestitures in life sciences, product life cycle transactions, and capital raising. Earlier roles include positions at King Pharmaceuticals, Inc., Bristol-Myers Squibb, and Bergen Brunswig Corporation. Ms. Kogan was a member of the board of Cardax, Inc. and served as chairperson of the compensation committee and a member of the audit committee. 

Ms. Kogan is a graduate of the SCALE program at Southwestern University School of Law and graduated cum laude from Columbia University, Barnard College, with a B.A. in economics.